Publicatie

Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant

Tijdschriftbijdrage - Tijdschriftartikel

We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron.

Tijdschrift: NPJ vaccines

ISSN: 2059-0105

Issue: 1

Volume: 7

Jaar van publicatie:2022

Trefwoorden:BNT162b2 vaccine, SARS-CoV-2 Omicron variant

PubMed Central Id: PMC8904765
Institutional Repository URL: https://cris.vub.be/ws/files/97818432/83827302.pdf
DOI: https://doi.org/10.1038/s41541-022-00459-z
Scopus Id: 85126215658
ORCID: /0000-0003-1208-6289/work/112704368
WoS Id: 000766164700002

Toegankelijkheid:Open

Zie ook: Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
Zie ook: Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant

Publicatie

Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant

Tijdschriftbijdrage - Tijdschriftartikel

Auteurs/uitgever

Onderzoekseenheden